Hemorrhagic Hemangioma Syndrome

Treatment Should Be Conservative

Published in Blood Weekly, January 20th, 2000

The treatment of hemorrhaghic hemangioma syndrome should be conservative, because it is a self-limiting disease, researchers indicated.

Antonio Gentil Martins reported on eight patients with this rare syndrome, with special emphasis on the two patients who were more recently treated. The report, titled "The Haemorrhagic Haemangioma Syndrome (Kasabach and Merritt)," was presented at the International Society of Pediatric Oncology and American Society for Pediatric Hematology/Oncology Joint Meeting, held September 13-18, 1999, in Montreal, Canada.

Less than 200 cases have been described in the literature since Kasabach and Merritt described a syndrome...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-01-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry